Devashish  Ohri net worth and biography

Devashish Ohri Biography and Net Worth

EVP of Avantor
Devashish Ohri is Executive Vice President, AMEA region of the company. Devashish Ohri is our Executive Vice President, AMEA, a position he has held since 2014. Prior to joining us, Mr. Ohri acted as Managing Director, South Asia for Life Technologies, a biotechnological company, from 2010 to 2014.

What is Devashish Ohri's net worth?

The estimated net worth of Devashish Ohri is at least $3.20 million as of May 26th, 2021. Mr. Ohri owns 154,095 shares of Avantor stock worth more than $3,202,094 as of November 22nd. This net worth estimate does not reflect any other investments that Mr. Ohri may own. Learn More about Devashish Ohri's net worth.

How do I contact Devashish Ohri?

The corporate mailing address for Mr. Ohri and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Devashish Ohri's contact information.

Has Devashish Ohri been buying or selling shares of Avantor?

Devashish Ohri has not been actively trading shares of Avantor during the last quarter. Most recently, Devashish Ohri sold 15,000 shares of the business's stock in a transaction on Wednesday, May 26th. The shares were sold at an average price of $31.87, for a transaction totalling $478,050.00. Following the completion of the sale, the executive vice president now directly owns 154,095 shares of the company's stock, valued at $4,911,007.65. Learn More on Devashish Ohri's trading history.

Who are Avantor's active insiders?

Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.

Are insiders buying or selling shares of Avantor?

In the last twelve months, insiders at the sold shares 2 times. They sold a total of 9,728 shares worth more than $240,247.97. The most recent insider tranaction occured on September, 5th when CAO Steven W Eck sold 3,525 shares worth more than $88,336.50. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.

Information on this page was last updated on 9/5/2024.

Devashish Ohri Insider Trading History at Avantor

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2021Sell15,000$31.87$478,050.00154,095View SEC Filing Icon  
5/24/2021Sell9,124$31.75$289,687.00148,219View SEC Filing Icon  
4/12/2021Sell100,160$32.37$3,242,179.20118,679View SEC Filing Icon  
10/5/2020Sell103,440$23.42$2,422,564.80170,111View SEC Filing Icon  
9/16/2020Sell35,000$23.02$805,700.00186,671View SEC Filing Icon  
7/30/2020Sell35,000$21.37$747,950.00186,671View SEC Filing Icon  
5/29/2020Sell65,000$18.84$1,224,600.00181,671View SEC Filing Icon  
2/18/2020Sell20,000$17.54$350,800.00177,143View SEC Filing Icon  
See Full Table

Devashish Ohri Buying and Selling Activity at Avantor

This chart shows Devashish Ohri's buying and selling at Avantor by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avantor Company Overview

Avantor logo
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $20.78
Low: $20.25
High: $20.85

50 Day Range

MA: $24.01
Low: $19.72
High: $27.70

2 Week Range

Now: $20.78
Low: $19.59
High: $28.00

Volume

7,511,720 shs

Average Volume

6,502,038 shs

Market Capitalization

$14.14 billion

P/E Ratio

45.17

Dividend Yield

N/A

Beta

1.35